ritanserin has been researched along with cgs 12066b in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Donát, P; Rodgers, RJ; Shepherd, JK | 1 |
Empson, RM; Gloveli, T; Heinemann, U; Schmitz, D | 1 |
Calama, E; Martín, ML; Morán, A; Ortíz de Urbina, AV; San Román, L | 1 |
3 other study(ies) available for ritanserin and cgs 12066b
Article | Year |
---|---|
Differential effects of novel ligands for 5-HT receptor subtypes on nonopioid defensive analgesia in male mice.
Topics: Aggression; Analgesia; Animals; Dioxins; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred DBA; Pyrazines; Quinolines; Quinoxalines; Reaction Time; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Spiro Compounds | 1991 |
Serotonin reduces polysynaptic inhibition via 5-HT1A receptors in the superficial entorhinal cortex.
Topics: 2-Amino-5-phosphonovalerate; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Entorhinal Cortex; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Free Radical Scavengers; Membrane Potentials; Neural Inhibition; Organ Culture Techniques; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses | 1998 |
Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biguanides; Biphenyl Compounds; Dose-Response Relationship, Drug; Electric Stimulation; Hindlimb; In Vitro Techniques; Infusions, Intravenous; Male; Methiothepin; Oxadiazoles; Perfusion; Piperazines; Pressure; Quinoxalines; Rats; Rats, Wistar; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT3 Receptor Agonists; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Vasoconstriction | 2005 |